Digital Poster Exhibition
65th Annual Meeting Society of Thrombosis and Hemostasis Research
65th Annual Meeting Society of Thrombosis and Hemostasis Research
A. Abendroth
Main-Author
L. Alberio
Co-Author
- Evaluation of different processing methods to label platelets for in vivo studies
- Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
- Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
- Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
M. C. Alessi
Co-Author
- Evolution of platelet phenotype during SARS-CoV-2 infection
- GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
A. Aliotta
Co-Author
- Evaluation of different processing methods to label platelets for in vivo studies
- Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
- Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
T. Anderle
Co-Author
V. Andreozzi
Co-Author
C. Ay
Co-Author
- Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
- Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
R. Beier
Co-Author
D. Bernot
Co-Author
- Evolution of platelet phenotype during SARS-CoV-2 infection
- GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
D. Bertaggia Calderara
Main-Author
Co-Author
- Evaluation of different processing methods to label platelets for in vivo studies
- Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
C. Bidlingmaier
Main-Author
M. Binder
Main-Author
I. Birschmann
Co-Author
S. Bockel
Main-Author
C. Bode
Co-Author
B. Bomke
Co-Author
S. Bonanad
Main-Author
E. Bontekoe
Co-Author
- Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
- Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
- Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
R. Bottega
Co-Author
C. Bovet
Co-Author
P. Bradacova
Main-Author
Co-Author
P. T. Brinkkoetter
Co-Author
N. Buchtele
Main-Author
Co-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
U. Budde
Co-Author
L. Buresch
Co-Author
V. Buxhofer-Ausch
Co-Author
T. Chang
Co-Author
P. Claar
Co-Author
- In vitro characterization of K5A and K5R variants of Factor IX
- Characterization of rFIX fusion proteins enabling subcutaneous administration
D. Crettaz
Co-Author
C. De Ford
Co-Author
B. Dharavath
Main-Author
- Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
R. Dieter
Co-Author
R. Dieter Jr.
Co-Author
B. Dixer
Co-Author
R. Djedidi - Amrane
Main-Author
H. Domanovits
Co-Author
L. Donner
Co-Author
J. Dreier
Co-Author
H. Eichler
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
I. Elalamy
Co-Author
- International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.
- Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
M. Elvers
Co-Author
- Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets
- The role of platelet mitochondrial function for platelet mediated Aβ40 aggregation
C. Escuriola-Ettinghausen
Co-Author
- Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
M. Faleschini
Co-Author
J. Fareed
Co-Author
- Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
- Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
- Hepatic Disorders Contribute to Platelet Dysfunction
- Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
- Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
T. Feige
Main-Author
M. Fillitz
Co-Author
B. Fischer
Co-Author
J. Fischer
Co-Author
R. Fischer
Main-Author
Co-Author
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
T. Flasch
Co-Author
T. Flieder
Main-Author
G. Fontana
Main-Author
P. Fontana
Co-Author
- Insight into the role of miR-223-3p in regulating platelet reactivity
- Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland
M. Fraga
Co-Author
C. Freiburg
Co-Author
C. Gachet
Co-Author
L. Garderet
Co-Author
H. Gebhart
Co-Author
J. Gebhart
Co-Author
B. Gerber
Co-Author
G. Gerotziafas
Co-Author
- Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
- Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
- International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.
- Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
T. Giangregorio
Co-Author
G. Goldmann
Co-Author
J. Goldstein
Main-Author
L. Graf
Co-Author
H.-J. Groß
Co-Author
M. Grube
Co-Author
N. Hagedorn
Main-Author
S. Halimeh
Co-Author
C. Hardy
Co-Author
- In vitro characterization of K5A and K5R variants of Factor IX
- Characterization of rFIX fusion proteins enabling subcutaneous administration
J. Harenberg
Co-Author
- Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test
- Impact of DOAC Dipstick test and relation to plasma and urine concentrations to exclude the presence of clinically relevant concentrations of DOACs in real-life patient setting – study protocol and case reports
- Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
C. Hart
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
- Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF
H. Haslacher
Co-Author
B. Hechler
Co-Author
I. Hegemann
Main-Author
S. Heimerl
Co-Author
H. Herkner
Co-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
W. Herr
Co-Author
H.-J. Hertfelder
Main-Author
S. Hetjens
Main-Author
A. Hlusi
Co-Author
- Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
- Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
S. Hofer
Co-Author
T. Hoffmann
Co-Author
K. Holstein
Main-Author
Co-Author
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
S. Holzhauer
Co-Author
D. Hoppenstaedt
Co-Author
- Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
- Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
- Hepatic Disorders Contribute to Platelet Dysfunction
- Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.
M. Höpting
Main-Author
B. Ho-Tin-Noé
Co-Author
M. Iacobelli
Co-Author
O. Iqbal
Co-Author
- Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
- Hepatic Disorders Contribute to Platelet Dysfunction
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
E. Janus-Bell
Main-Author
W. Jeske
Main-Author
Co-Author
B. Jilma
Co-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
- Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
S. Kathemann
Co-Author
J. Kaufeld
Co-Author
B. Kemkes-Matthes
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
K. Kentouch
Co-Author
R. Klamroth
Co-Author
- Monitoring pain and joint health in patients with haemophilia
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
C. Knabbe
Co-Author
P. N. Knöbl
Co-Author
R. Knöfler
Co-Author
F. Knüttgen
Co-Author
R. H. Ko
Co-Author
A. Kouta
Main-Author
Co-Author
- Quantification of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics.
- Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
R. Kraemer
Co-Author
B. Krammer-Steiner
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
D. Kranzhöfer
Main-Author
M. Krohn-Grimberghe
Co-Author
M. Krstic
Co-Author
I. Krueger
Main-Author
P. Kuebler
Co-Author
K. Kurnik
Co-Author
- A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII
- Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
A. K. Larsen
Co-Author
L. M. Lepatan
Co-Author
Y. Li
Co-Author
T. Lissitchkov
Co-Author
C. Liu
Co-Author
- Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
- Examination of the Rac-modulator ArhGAP15 in platelet activation.
A. Lovrenčić-Huzjan
Co-Author
J. Machacek
Main-Author
M. E. Mancuso
Main-Author
- A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
- A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
Co-Author
P. Mangin
Co-Author
C. Marconi
Co-Author
S. Margetić
Main-Author
A. Margraf
Main-Author
- Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
- Examination of the Rac-modulator ArhGAP15 in platelet activation.
G. Maro
Co-Author
- A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
- A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
S. Marten
Main-Author
A. Martin
Co-Author
A. Matzdorff
Co-Author
E. Mbemba
Co-Author
D. Mehic
Main-Author
A. Mendez
Co-Author
J. Menne
Co-Author
A. Merrelaar
Main-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
Co-Author
W. Miesbach
Co-Author
C. Mischung
Co-Author
W. Mondorf
Main-Author
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
D. Moradpour
Co-Author
P. E. Morange
Co-Author
- Evolution of platelet phenotype during SARS-CoV-2 infection
- GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
M. C. Morel-Kopp
Co-Author
C. Mouriaux
Co-Author
B. Müller
Co-Author
C. Muret
Main-Author
S. Naas
Main-Author
A. Nagao
Co-Author
M. Nagler
Co-Author
C. Negrier
Main-Author
A. Nemani
Main-Author
U. Neudorf
Co-Author
F. Nimmerjahn
Co-Author
A. Nimtz-Talaska
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
P. Noris
Co-Author
R. Núñez
Co-Author
J. Oldenburg
Main-Author
Co-Author
M. Olivieri
Co-Author
- Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
- Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
- A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
- A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
I. Pabinger
Main-Author
Co-Author
- Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
- Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia
N. Papa
Co-Author
L. Papageorgiou
Main-Author
- International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.
- Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
A. Pavlova
Co-Author
- Type 2B von Willebrand disease – a rare cause of neonatal thrombocytopenia
- Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
A. Pecci
Co-Author
S. Pestel
Co-Author
- In vitro characterization of K5A and K5R variants of Factor IX
- Characterization of rFIX fusion proteins enabling subcutaneous administration
C. Pfrepper
Co-Author
M. Pink
Co-Author
J. L. Poveda
Co-Author
J. Prochazkova
Co-Author
- Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
- Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
M. Prudent
Co-Author
A. Rath
Co-Author
N. Receveur
Co-Author
D. Reinhardt
Co-Author
J. Reiser
Co-Author
M. Reschke
Main-Author
Co-Author
H. Richter
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
A. Roesch
Main-Author
C. Rudtke
Co-Author
M. J. Rummel
Co-Author
G. Ruzicka
Co-Author
M. Sabbah
Co-Author
F. Sanabria
Co-Author
J. Sangalli-Baruffaldi
Co-Author
C. Santoro
Co-Author
- A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
- A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
S. Santos
Co-Author
A. Savoia
Co-Author
R. Scharf
Co-Author
A. Schmidt
Co-Author
D. Schmoldt
Co-Author
C. Schoergenhofer
Co-Author
C. Schörgenhofer
Co-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
T. Schramm
Co-Author
J. Schulte
Co-Author
M. Schwameis
Co-Author
- A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study
- Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
- Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
W. Seifert
Co-Author
M. Seri
Co-Author
K. Severin
Co-Author
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
W. Seyfert-Brandt
Co-Author
A. Shang
Co-Author
M. Sigmund
Co-Author
L. Slavík
Main-Author
Co-Author
- The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
- Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
P. Sommerer
Co-Author
- A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A
- A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A. Spiel
Co-Author
F. Steffen
Co-Author
J. D. Studt
Co-Author
S. Šupraha Goreta
Co-Author
T. Tesanovic
Co-Author
S. Thouroude
Main-Author
O. Tiebel
Co-Author
A. Tiede
Co-Author
K. Trautmann
Co-Author
M. Türknetz
Co-Author
J. Úlehlová
Co-Author
- The occurrence of trombocythopathy in CLL patients treated with Ibrutinib
- Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
- Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
J. Ullrychova
Co-Author
- Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?
- Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
B. Vandewalle
Co-Author
P. Vandreden
Co-Author
- International Myeloma Working Group ( IMWG) score accuracy in multiple myeloma patients: need for action.
- Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease
P. Van Dreden
Co-Author
- Prolonged chemotherapeutic stress is accompanied by an aggressive and singular vascularization process with a high thrombogenic potential in Colorectal Cancer
- Cancer cell-derived microparticles expressing tissue factor have pivotal role on the procoagulant shift of endothelial cells
L. Völker
Main-Author
T. Vollmer
Co-Author
K. von Bargen
Co-Author
C. von zur Mühlen
Co-Author
C. Weiss
Co-Author
S. Wenning
Co-Author
C. Wermes
Co-Author
- Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
- Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
- Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
K. Wieschhaus
Co-Author
D. Willbold
Co-Author
M. Wolny
Co-Author
W. A. Wuillemin
Co-Author
Y. Yao
Co-Author
A. Zarbock
Co-Author
- Thrombopoietin levels in sepsis and septic shock - a meta-analysis.
- Examination of the Rac-modulator ArhGAP15 in platelet activation.
M. G. Zermatten
Main-Author
Co-Author
- Evaluation of different processing methods to label platelets for in vivo studies
- Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
S. Zhou
Co-Author